Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9598768 | 0.98 | PARP1 (0.34) | PARP1TP53 | |
| SCHEMBL3411010 | 0.64 | — | — | |
| SCHEMBL9155013 | 0.58 | PARP1 (0.45) | PARP1TP53 | |
| SCHEMBL25296578 | 0.55 | PARP1 (0.32) | PARP1 | |
| SCHEMBL1133601 | 0.52 | PARP1 (1.00) | PARP1TP53 | |
| SCHEMBL6136738 | 0.52 | AHR (0.48) | — | |
| SCHEMBL50865 | 0.52 | MAOA (0.50) | PARP1 | |
| SCHEMBL6643583 | 0.52 | CYP1A2 (0.37) | — | |
| SCHEMBL30252635 | 0.52 | MAOA (0.50) | PARP1 | |
| Hydrochloric Acid SCHEMBL2710069 | 0.51 | MAOA (0.48) | PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11002524-B2 | Cyclic compounds and process for the preparation thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2021-05-11 | — | — | US | disclosed |
| US-20200249002-A9 | A CYCLIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-08-06 | — | — | US | disclosed |
| EP-3436454-A1 | A CYCLIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF | Council of Scientific and Industrial Research (IN) | 2019-02-06 | — | — | EP | disclosed |
| EP-3019498-B1 | NOVEL TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | COUNCIL SCIENT IND RES (IN) | 2018-12-26 | — | — | EP | disclosed |
| US-9822113-B2 | Tricyclic compounds and process for preparation thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-11-21 | — | — | US | disclosed |
| WO-2017168447-A1 | A CYCLIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-10-05 | — | — | WO | disclosed |
| US-20160152616-A1 | NOVEL TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-06-02 | — | — | US | disclosed |
| EP-0642508-A1 | TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1995-03-15 | — | — | EP | disclosed |
| WO-1993008188-A1 | TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1993-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152616-A1 | NOVEL TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | CCKAR, HKDC1, NRDC | PARP1 731/4885TP53 3481/4885 |
| US-11002524-B2 | Cyclic compounds and process for the preparation thereof | VIP, TREH, CCKAR | PARP1 1835/4885TP53 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.